Clinical Trial Update: Rosuvastatin in Rheumatoid Arthritis (RORA) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for rosuvastatin in rheumatoid arthritis across Phase 2 and Phase 3, indicating completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: University of Dundee | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED